259 related articles for article (PubMed ID: 21501208)
1. Increased expression of distinct galectins in multiple sclerosis lesions.
Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
[TBL] [Abstract][Full Text] [Related]
2. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1).
Moreels M; Vandenabeele F; Dumont D; Robben J; Lambrichts I
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):532-46. PubMed ID: 18005096
[TBL] [Abstract][Full Text] [Related]
3. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
[TBL] [Abstract][Full Text] [Related]
5. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
6. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
[TBL] [Abstract][Full Text] [Related]
7. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
[TBL] [Abstract][Full Text] [Related]
8. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
Mult Scler; 2011 Oct; 17(10):1194-201. PubMed ID: 21613335
[TBL] [Abstract][Full Text] [Related]
9. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
Melief J; Schuurman KG; van de Garde MD; Smolders J; van Eijk M; Hamann J; Huitinga I
Glia; 2013 Nov; 61(11):1848-61. PubMed ID: 24014207
[TBL] [Abstract][Full Text] [Related]
10. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
[TBL] [Abstract][Full Text] [Related]
12. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.
Satoh J; Tabunoki H; Yamamura T; Arima K; Konno H
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):99-107. PubMed ID: 17239012
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
van Horssen J; Vos CM; Admiraal L; van Haastert ES; Montagne L; van der Valk P; de Vries HE
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):585-93. PubMed ID: 17083473
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases.
Aoki-Yoshino K; Uchihara T; Duyckaerts C; Nakamura A; Hauw JJ; Wakayama Y
Acta Neuropathol; 2005 Sep; 110(3):281-8. PubMed ID: 16133546
[TBL] [Abstract][Full Text] [Related]
15. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
Koning N; Swaab DF; Hoek RM; Huitinga I
J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
[TBL] [Abstract][Full Text] [Related]
16. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
Koning N; Bö L; Hoek RM; Huitinga I
Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
[TBL] [Abstract][Full Text] [Related]
19. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
Lu JQ; Fan Y; Mitha AP; Bell R; Metz L; Moore GR; Yong VW
J Neuropathol Exp Neurol; 2009 Feb; 68(2):179-89. PubMed ID: 19151622
[TBL] [Abstract][Full Text] [Related]
20. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
